Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05719779 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Tolerance and Benefits of Mandibular Advanced Device for Snoring and Sleep Apnea in Oropharyngeal Cancer.

Study acronym: Ronco-Onco
StatusUnknown
PhaseNot applicable
Started2023-02-03
View on ClinicalTrials.gov ↗
Record status
This record was last updated August 15, 2024 (before its estimated December 30, 2025 completion). Its status may not reflect the trial's current state.

Amendment history

2026-09-06
minor
Trial status changed: Recruiting → Unknown
2024-08-14
minor
Study Status v2
Trial statusRecruiting→Unknown
Primary completion date2025-06-30→2025-12-30
Completion date2025-06-30→2025-12-30
2023-05-09
notable
Not Yet Recruiting→Recruiting Study Identification, Study Status, Sponsor/Collaborators, Contacts/Locations v1
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2023-03-30→confirmed 2023-02-03
Study sites0→1
2023-01-30
minor
Original filing
Evaluation of the Tolerance and Benefits of Mandibular Advanced Device (MAD) for Snoring and Sleep Apnea in Patients with Oropharyngeal Cancer (OPC): Mixed Design Study.
Trial Details
NCT Number NCT05719779
Lead Sponsor Centre hospitalier de l'Université de Montréal (CHUM)
Conditions Oral Cancer, Pharynx Cancer, Sleep Apnea, Snoring, Oral Squamous Cell Carcinoma
Enrollment 35 participants
Start Date 2023-02-03
Primary Completion 2025-12-30 (estimated)
Study Completion 2025-12-30 (estimated)
Updated on ClinicalTrials.gov 2024-08-15